Moderna shares fall after judge sides with Arbutus in patent fight
(Reuters) -Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order...
(Reuters) -Shares of Moderna fell 4% on Wednesday after a U.S. judge issued an order...
(Reuters) – Shares of Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and...
By Michael Erman and Bhanvi Satija (Reuters) -Pfizer reported a surprise quarterly profit on Tuesday,...
By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson on Tuesday forecast revenue growth...
By Bhanvi Satija and Michael Erman (Reuters) – Pfizer on Tuesday urged investors to focus...
By Michael Erman and Ahmed Aboulenein NEW YORK/WASHINGTON (Reuters) – Americans have started rolling up...
By Ahmed Aboulenein and Michael Erman (Reuters) -Around 4 million Americans received the updated COVID-19...
(Reuters) – Moderna said on Thursday an initial study data showed its updated COVID-19 vaccine...
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals...
(Reuters) -The US Federal Trade Commission (FTC) has sought additional information and documentary material related...